OptimizeRx Corp - Common Stock (OPRX)

CUSIP: 68401U204

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Common Stock
Shares outstanding
18,580,860
Total 13F shares
4,513,539
Share change
+327,049
Total reported value
$57,409,000
Price per share
$12.72
Number of holders
40
Value change
+$4,428,868
Number of buys
24
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 68401U204?
CUSIP 68401U204 identifies OPRX - OptimizeRx Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q1 2019

As of 31 Mar 2019, OptimizeRx Corp - Common Stock (OPRX) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,513,539 shares. The largest 10 holders included Park West Asset Management LLC, WOLVERINE ASSET MANAGEMENT LLC, VANGUARD GROUP INC, WASATCH ADVISORS INC, Russell Investments Group, Ltd., PERKINS CAPITAL MANAGEMENT INC, Venator Capital Management Ltd., Manatuck Hill Partners, LLC, 1492 Capital Management LLC, and AVENIR CORP. This page lists 40 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.